Vaccine efficacy against primary CMV infection ranged from 6 per cent to 23 per cent, depending on case definition, falling short of Moderna’s predefined target
The combination is approved for advanced endometrial carcinoma that is pMMR or not MSI-H and has progressed after prior systemic therapy
Acquisition expands AbbVie's psychiatry pipeline with the addition of a next-generation psychedelic compound currently in Phase 2 development for the treatment of major depressive disorder
TTK Healthcare has reported total income of Rs. 222.58 crore during the period ended September 30, 2025
Breakthrough expands proactive TB screening from birth to 15 years, ensuring faster and more accurate diagnosis
This new facility strengthens Latin America as a collaborative hub
Triamcinolone Acetonide injectable suspension USP is indicated for various autoimmune, inflammatory, and other conditions
Treatment with TUKYSA was well-tolerated, with a safety profile consistent with previously known profiles of the individual agents
The Cranbury facility represents a strategic advancement of the company's operations in the Unted States
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
